SEC Form D filing

Ceretype Neuromedicine, Inc., 2025-12-18

An SEC Form D private-offering notice from Cambridge, MA, a $400,000 filer-stated offering target in Biotech. Filed 2025-12-18. The source filing is one click away. For companies that filed this week, open the live feed.

What this filing says

Ceretype Neuromedicine, Inc. site↗ Verified via SEC Form D

Biotechnology company using functional MRI based brain activity biomarkers to support neuropsychiatric drug development; a spinout of Harvard Medical School and Brigham and Women's Hospital research.

Filed 2025-12-18Filed to raise $400,000First money in 2024-08-06Raised so far $400,000HQ (as filed) Cambridge, MASector Biotech web-verified against the company’s own siteStage (inferred) Pre-seedCall status Late filing
Source linked the Form D on EDGAR↗Website verified ceretype.com↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source